Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Peginterferon Alfa-2b (PEG-Intron) for Plexiform Neurofibromas

NCT00396019 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00396019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00396019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Peginterferon Alfa-2b (PEG-Intron) for Plexiform Neurofibromas
Lead sponsor
University of Pittsburgh
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2006
Completion date
April 30, 2014
Enrollment
86 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

plexiform neurofibroma